ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Notch2 Directs aTreg Cell Fate Toward Immunoregulation or Inflammatory Pyroptosis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Activated regulatory T cells (aTregs) exhibit potent immunosuppressive functions and can migrate to tissues, playing a crucial role in attenuating inflammatory responses. The precise role and molecular mechanisms through which Notch2 regulates the immunoregulatory functions of aTregs remain incompletely elucidated. Here, we elucidate the mechanisms through which Notch2 influences aTreg dynamics and mitigates allergic rhinitis (AR) development. Mechanistically, the targeted knockout of Notch2 in aTregs resulted in decreased Foxo1 expression and elevated phosphorylated ASC (p-ASC) levels, culminating in GSDMD-N-mediated pyroptosis in aTregs. Moreover, the Notch2 intracellular domain (NICD2) promoted the nuclear translocation of RREB1 through direct protein-protein interactions, thereby enhancing Foxo1 transcriptional activity. Importantly, the adoptive transfer of Notch2+ aTregs significantly reduced Th2 inflammatory responses in AR mice, providing an effective therapeutic strategy for managing AR-related inflammation. Overall, our findings establish a novel paradigm in the pathogenesis of AR in which Notch2 expression dictates the functional dichotomy of aTregs in maintaining their immunoregulatory capacity or undergoing inflammatory pyroptosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.